Back to today’s briefing

Story perspectives

Trump Reverses Drug Pricing Order; Medicare Caps Remain

1/30/2025

50 5

Summary

Story summary

On January 20, 2025, President Trump overturned Biden's Executive Order designed to explore innovative drug pricing models. Despite this move, the established caps on Medicare drug costs and the Inflation Reduction Act's price negotiation provisions remain intact. As Trump's administration unfolds, the fate of drug pricing reforms hangs in the balance, leaving many to wonder what lies ahead.

History

Historical Context

On January 20, 2025, President Trump revoked Biden's Executive Order aimed at innovative drug pricing models. This mirrors past executive actions, notably Trump's 2017 initiatives to combat the opioid crisis, which highlighted ongoing struggles with drug pricing and addiction. The current situation raises concerns about the future of healthcare reforms, reflecting historical tensions between differing presidential approaches to drug policy.

1 of 2

Story summary

On January 20, 2025, President Trump overturned Biden's Executive Order designed to explore innovative drug pricing models. Despite this move, the established caps on Medicare drug costs and the Inflation Reduction Act's price negotiation provisions remain intact. As Trump's administration unfolds, the fate of drug pricing reforms hangs in the balance, leaving many to wonder what lies ahead.

1 / 2